D-0927-2018 Class II Terminated
FDA drug recall D-0927-2018 was initiated by LUPIN SOMERSET on Jun 28, 2018 and is designated Class II. Reason for recall: Subpotent Drug and Failed Content Uniformity. The recall status is terminated (terminated Mar 6, 2023). Affected quantity: 3456 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 18, 2018
- Initiation Date
- Jun 28, 2018
- Termination Date
- Mar 6, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3456 cartons
Product description
Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, UPC 343386-450-114, NDC 43386-450-11
Reason for recall
Subpotent Drug and Failed Content Uniformity.
Distribution pattern
Nationwide within the US
Code information
Lot#: S700065, Exp. 02/2019; 700619, Exp. 08/2019
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0927-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026